Moderna Inc.

05/01/2025 | Press release | Archived content

CN-1 Crigler-Najjar Syndrome Type 1 - mRNA-3351 Development Program

Moderna Inc. published this content on May 01, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on July 18, 2025 at 16:03 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at support@pubt.io